To reduce the risks and harms associated with opioid use, it is crucial to understand its health and social impacts. To this end, CCSA collaborates with partners to gain a better understanding of the risks and harms of opioid use and supports evidence-based decisions about opioid policy and practice. CCSA also recognizes that interventions for opioid-related harms must address the broader context of polysubstance use and meet the specific needs of different groups and communities.
What Are Opioids?
Opioids are available in both pharmaceutical and non-pharmaceutical forms. Common opioid pharmaceutical medications, such as codeine, fentanyl, morphine, oxycodone and diacetylmorphine, are primarily used to treat pain. However, people may also use these products for non-medical purposes. Fentanyl and fentanyl analogues of non-pharmaceutical origin are illegally manufactured and are the most widely available opioids in Canada's unregulated drug supply.
Most harms associated with opioids are caused by synthetic opioids, such as fentanyl and to a lesser extent nitazenes, which can be consumed unknowingly through the unregulated drug supply. The presence of these opioids in other substances significantly increases the risk of drug toxicity deaths, as they are extremely potent and can be fatal, even in small amounts.
About the Opioid Toxicity Crisis
The opioid toxicity crisis in Canada has evolved, and the factors that contribute to it are complex and multifaceted. Factors that once played a central role, such as high levels of prescription opioid use and diversion, no longer have as significant an impact. The current crisis is influenced by several factors, including:
- Psychological, social and biological risk factors, such as genetics, adverse childhood experiences, trauma, mental health, poverty, lack of secure housing and other social determinants of health;
- The lack of a comprehensive spectrum of care, including harm reduction and treatment services, that can respond to an individual's physical, mental health and social needs in a timely manner;
- The unpredictable dose and contents of fentanyl from the unregulated drug supply, which can lead to increased risk of drug poisoning and other harms from contaminants like synthetic opioids and non-medical benzodiazepines;
- Disruptions to the drug supply during the COVID-19 pandemic, which led to increased toxicity combined with reduced access to supports and services;
- Unintentional polysubstance exposure from the unregulated drug supply and intentional polysubstance use that includes use of opioids with stimulants;
- Stigma toward those who use substances or are living with substance use disorders;
- Lack of access to prescription opioids, leading individuals to use opioids from the unregulated drug supply;
- Lack of awareness or access to alternative treatments for pain; and
- Use of opioids diverted from friends’ and family members’ prescriptions.
Get to know our team of experts
Alexander Caudarella, MDCM CCFP AM ABAM(d)
CEO
Area of Expertise:
Samantha King, PhD
Research and Policy Analyst
Area of Expertise:
Sheena Taha, PhD
Associate Director, Quality and Accountability
Area of Expertise:
Heading
Contact an Expert
Latest CCSA Updates
WHO pushes countries to raise prices on sugary drinks, alcohol and tobacco by 50%
Heading
Guidance, Tools and Resources
CCSA produces research-based publications, tools, and resources to support evidence-based decision-making on substance use health issues. Select your area of interest from the six categories below:
Heading
Substances
Delve into key resources on commonly used substances, such as alcohol, cannabis, opioids, stimulants and psychedelics. Learn about their effects, usage patterns, associated health and social consequences, and harm reduction considerations
Heading
Personal and Societal Impacts
Get insights on the personal and societal impacts of substance use and addiction , including gambling and impaired driving, and their effects on health, safety, and social well-being. Learn about effective prevention and harm-reduction strategies in various sectors.
Heading
Communities
Communities share common interests, values or goals, and interact with one another to build relationships and help networks. These materials support more inclusive, equitable, and community-informed responses to substance use and addiction. Dive into resources highlighting people with lived and living experience, stigma, sex- and gender-based analysis, Indigenous Peoples, and housing.
Heading
Treatment and Prevention
Explore medical, psychological, and social approaches aimed at helping individuals avoid or recover from substance use disorders. Get the facts on public health topics and learn about collaborative efforts to reduce stigma and promote more equitable, inclusive responses to substance use.
Heading
Youth
Learn about factors influencing substance use in young people, including childhood trauma and brain development, and get tools to support adult allies in leading meaningful, evidence-informed conversations with youth. Content promotes early prevention, harm reduction and supportive environments for youth up to age 25.
Heading
Substance Use and the Workplace
Substance use has a significant impact on the workplace, potentially affecting safety, productivity and employee well-being. Explore research on substance use in various industries. Resources support workplace leaders in building more supportive, stigma-free environments through practical strategies, improved approaches and initiative-taking education.
